Las Vegas, NV -- (SBWIRE) -- 12/11/2013 -- PennyStockEarnings team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks. Our Today’s Focus is on: Merrimack Pharmaceuticals Inc (NASDAQ:MACK), Phoenix New Media Ltd ADR (NYSE:FENG), Halozyme Therapeutics, Inc. (NASDAQ:HALO), Apollo Investment Corp. (NASDAQ:AINV)
Merrimack Pharmaceuticals Inc (NASDAQ:MACK) managed to keep its fall at -4.25% on below -normal volume of 1.77M shares. The stock settled at $4.28 after floating in a range of $4.25 to $4.62. Its latest price has reached market capitalization of $438.085 million. Its 52-week range has been $2.05 to $7.09. Merrimack Pharmaceuticals, Inc. is a biopharmaceutical company discovering, developing and preparing to commercialize medicines paired with companion diagnostics for the treatment of serious diseases, with an initial focus on cancer.
Has MACK Found The Bottom and Ready To Move Up? Find Out Here
Phoenix New Media Ltd ADR (NYSE:FENG) traded down on a volume of 1.72 million, higher than its standard daily volume. Shares have dropped-4.21% to $8.87. Over the last twelve months, the stock has gained 178.06% and faced a worst price of $3.12. Phoenix New Media Limited (PNM) is a new media company providing content on an integrated platform across Internet, mobile and television (TV) channels in China. PNM enables consumers to access professional news and other content and share user-generated content (UGC), on the Internet and through their mobile devices.
Has FENG Found The Bottom And Ready To Gain Momentum? Find Out Here
Halozyme Therapeutics, Inc. (NASDAQ:HALO) settled 2.26% higher at $14.01 on above-normal volume of 1.72M shares during the last trading day. The stock has its 12-month high at $15.39 and 52-week low price was $5.03. It traded in a range of $13.55 to $14.13 during the last trading day. Halozyme Therapeutics, Inc. is a biopharmaceutical company. The Company’s research focuses primarily on human enzymes that alter the extracellular matrix. The Company’s pipeline consists of multiple clinical stage products in diabetes, oncology and dermatology.
Why Should Investors Buy HALO After the Recent Fall? Just Go Here and Find Out
In the last trading session, Apollo Investment Corp. (NASDAQ:AINV) was down on high volume, trading at a volume of 1.72M shares versus its average daily volume of 1.50 million shares. At $8.78, the stock has attained market capitalization of $1.97 billion. Apollo Investment Corporation (Apollo Investment) is a closed-end, non-diversified management investment company that has elected to be treated as a business development company. Its investment objective is to generate current income and capital appreciation. It invests primarily in various forms of debt investments, including senior secured loans, subordinated and mezzanine investments and/or equity in private middle market companies. From time to time, Apollo Investment may also invest in the securities of public companies. Its portfolio consists of investments in subordinated.
Why Should Investors Buy AINV After the Recent Fall? Just Go Here and Find Out
PennyStockEarnings.com is keen to discover penny stocks with the potential to make short and long-term gains.
PSE Team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks.
PLEASE NOTE WELL: The employees of PennyStockEarnings.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockEarnings.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockEarnings.com is not offering securities for sale. Neither PennyStockEarnings.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockEarnings.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockEarnings.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer Here: http://www.pennystockearnings.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)